Emlen L. Cresson

539 total citations
20 papers, 352 citations indexed

About

Emlen L. Cresson is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Emlen L. Cresson has authored 20 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Cell Biology. Recurrent topics in Emlen L. Cresson's work include Biotin and Related Studies (7 papers), Click Chemistry and Applications (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Emlen L. Cresson is often cited by papers focused on Biotin and Related Studies (7 papers), Click Chemistry and Applications (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Emlen L. Cresson collaborates with scholars based in United States. Emlen L. Cresson's co-authors include Lemuel D. Wright, Helen R. Skeggs, Donald E. Wolf, Karl Folkers, William C. Randall, Carl H. Hoffman, William C. Lumma, Joel R. Huff, Richard D. Hartman and James P. Springer and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Bacteriology.

In The Last Decade

Emlen L. Cresson

20 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emlen L. Cresson United States 14 218 130 93 50 29 20 352
George S. Serif United States 13 278 1.3× 85 0.7× 27 0.3× 32 0.6× 12 0.4× 37 470
Gloria Rosso United States 11 285 1.3× 71 0.5× 30 0.3× 66 1.3× 12 0.4× 15 353
Petronio Pasquali Italy 12 364 1.7× 93 0.7× 40 0.4× 44 0.9× 52 1.8× 35 474
David R. Patek United States 7 223 1.0× 41 0.3× 35 0.4× 77 1.5× 31 1.1× 8 362
Michael R. Hollaway United Kingdom 14 265 1.2× 44 0.3× 131 1.4× 26 0.5× 21 0.7× 22 455
George W. Kosicki Canada 14 336 1.5× 38 0.3× 68 0.7× 96 1.9× 26 0.9× 25 528
William B. Novoa United States 10 379 1.7× 29 0.2× 148 1.6× 90 1.8× 33 1.1× 11 560
Carl H. Hoffman United States 12 331 1.5× 85 0.7× 24 0.3× 132 2.6× 42 1.4× 19 444
Ruth M. Flynn United Kingdom 5 192 0.9× 29 0.2× 41 0.4× 53 1.1× 13 0.4× 9 304
Dolores Bertoli United States 9 166 0.8× 47 0.4× 57 0.6× 103 2.1× 13 0.4× 9 382

Countries citing papers authored by Emlen L. Cresson

Since Specialization
Citations

This map shows the geographic impact of Emlen L. Cresson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emlen L. Cresson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emlen L. Cresson more than expected).

Fields of papers citing papers by Emlen L. Cresson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emlen L. Cresson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emlen L. Cresson. The network helps show where Emlen L. Cresson may publish in the future.

Co-authorship network of co-authors of Emlen L. Cresson

This figure shows the co-authorship network connecting the top 25 collaborators of Emlen L. Cresson. A scholar is included among the top collaborators of Emlen L. Cresson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emlen L. Cresson. Emlen L. Cresson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saari, Walfred S., David W. Cochran, Emlen L. Cresson, et al.. (1983). Preparation of some 10-[3-(dimethylamino)propyl]-10H-pyrazino[2,3-b][1,4]benzothiazines as potential neuroleptics. Journal of Medicinal Chemistry. 26(4). 564–569. 17 indexed citations
2.
Lumma, William C., et al.. (1983). Piperazinylimidazo[1,2-a]pyrazines with selective affinity for in vitro .alpha.-adrenergic receptor subtypes. Journal of Medicinal Chemistry. 26(3). 357–363. 40 indexed citations
3.
Randall, William C., et al.. (1983). Multiple central α2 adrenoceptors of avian and mammalian species. Biochemical Pharmacology. 32(12). 1933–1940. 13 indexed citations
4.
Lumma, William C., et al.. (1983). ChemInform Abstract: PIPERAZINYLIMIDAZO(1,2‐A)PYRAZINES WITH SELECTIVE AFFINITY FOR IN VITRO α‐ADRENERGIC RECEPTOR SUBTYPES. Chemischer Informationsdienst. 14(34). 2 indexed citations
6.
Randall, William C., Paul Anderson, Emlen L. Cresson, et al.. (1979). Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomers. Journal of Medicinal Chemistry. 22(10). 1222–1230. 20 indexed citations
7.
Randall, William C., Emlen L. Cresson, Harvey Schwam, et al.. (1979). Quantitative structure-activity relationships involving the inhibition of glycolic acid oxidase by derivatives of glycolic and glyoxylic acids. Journal of Medicinal Chemistry. 22(6). 608–614. 19 indexed citations
8.
Wright, Lemuel D., Emlen L. Cresson, Helen R. Skeggs, et al.. (1956). Isolation of a New Acetate-replacing Factor. Journal of the American Chemical Society. 78(20). 5273–5275. 44 indexed citations
9.
Skeggs, Helen R., Lemuel D. Wright, Emlen L. Cresson, et al.. (1956). DISCOVERY OF A NEW ACETATE-REPLACING FACTOR. Journal of Bacteriology. 72(4). 519–524. 45 indexed citations
10.
Wright, Lemuel D., et al.. (1956). Biotin Derivatives in Human Urine. Experimental Biology and Medicine. 91(2). 248–252. 13 indexed citations
11.
Wright, Lemuel D., et al.. (1955). Biological Precursors of Biotin and/or Biotin L-Sulfoxide. Experimental Biology and Medicine. 89(2). 234–236. 8 indexed citations
12.
Wright, Lemuel D., et al.. (1954). Biotin l-Sulfoxide. II. The Isolation of a Crystalline Factor with Biotin Activity from Aspergillus niger Culture Filtrates. Journal of the American Chemical Society. 76(16). 4160–4163. 7 indexed citations
13.
Wright, Lemuel D., et al.. (1954). Biotin l-Sulfoxide. III. The Characterization of Biotin l-Sulfoxide from a Microbiological Source. Journal of the American Chemical Society. 76(16). 4163–4166. 22 indexed citations
14.
Wright, Lemuel D. & Emlen L. Cresson. (1954). Biotin l-Sulfoxide. I. The Occurrence of a Previously Unrecognized Form of Biotin in Certain Fermentation Sources. Journal of the American Chemical Society. 76(16). 4156–4160. 18 indexed citations
15.
Wright, L. D., et al.. (1954). Bioautography of Biotin and Certain Related Compounds. Experimental Biology and Medicine. 86(3). 480–483. 13 indexed citations
16.
Wright, Lemuel D. & Emlen L. Cresson. (1953). Isolation and Characterization of Diaminopimelic Acid from Culture Filtrate of an Escherichia coli Mutant. Experimental Biology and Medicine. 82(2). 354–358. 8 indexed citations
17.
Wright, Lemuel D., Emlen L. Cresson, Helen R. Skeggs, et al.. (1952). Isolation of Crystalline Biocytin from Yeast Extract. Journal of the American Chemical Society. 74(8). 1996–1999. 18 indexed citations
18.
Wright, Lemuel D., et al.. (1952). Biological Studies of Biocytin. Journal of the American Chemical Society. 74(8). 2004–2006. 16 indexed citations
19.
Wright, Lemuel D., Helen R. Skeggs, & Emlen L. Cresson. (1951). Amides and Amino Acid Derivatives of Biotin: Microbiological Studies. Journal of the American Chemical Society. 73(9). 4144–4145. 18 indexed citations
20.
Wright, Lemuel D., Emlen L. Cresson, Helen R. Skeggs, et al.. (1951). The Elucidation of Biocytin. Science. 114(2972). 635–636. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026